Patent Services · Biotech
Biotech Patent Attorney in Irvine & Orange County, CA
mjIP provides biotech patent representation in Irvine and across Orange County, led by USPTO-registered patent attorney Mandana Jafarinejad, Esq. With a B.S. in Biology and in-house experience as a patent attorney and research scientist at a Fortune 500 pharmaceutical company, she reads the science behind biotech inventions and drafts claims that hold up under USPTO examination. This page is part of the firm's broader patent services.
Biotech Inventions We Patent
- Recombinant DNA technology and expression systems
- Gene-editing methods and constructs
- Cell-based and gene therapies
- Diagnostic assays and biomarkers
- Bioreactor and bioprocessing methods
- Novel biological compounds and compositions
Why a Science Background Matters for Biotech Patents
Biotech claims live or die on technical precision. Enablement, written description, and claim scope all depend on how well the application explains the underlying biology. An attorney who understands the technology can anticipate examiner objections, support broad claims with the right disclosure, and position the invention for a durable grant.
From Invention Disclosure to Grant
mjIP guides biotech clients through a free consultation and patentability assessment, prior-art searching, application drafting, USPTO filing and prosecution, and portfolio expansion through continuations — coordinated with funding and development timelines. Protect the brand alongside the science with a biotech trademark attorney.
Working With Universities and Spin-Outs
Many biotech inventions begin in academic labs. mjIP also provides university tech transfer patent counsel for faculty founders and research teams in the Orange County corridor.
Common Questions
Frequently Asked Questions
A provisional application secures an early priority date and gives you 12 months to file a non-provisional (utility) application; it is not examined and does not become a patent on its own. For a biologic, founders often file a provisional to lock in a date before publishing or pitching, then file the utility application, which the USPTO examines and which can mature into an enforceable patent.
mjIP is based in Irvine at 1 Park Plaza, Suite 600, and works with biotech founders and R&D teams across Orange County, San Diego, and Southern California — in person or remotely.
Yes, if it is novel, non-obvious, and useful, and the application adequately describes and enables it. Method and composition claims are both common in biotech; the right mix depends on your technology and commercial goals.
Generally before any public disclosure, publication, or investor pitch that could create prior art. A provisional application can secure an early priority date while development continues.
Yes. mjIP works with solo founders and early-stage biotech teams across Orange County and San Diego, tailoring scope to your stage and budget.